This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, J. J.
Right arrow Articles by Stafford, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, J. J.
Right arrow Articles by Stafford, R. G.
Agricola
Right arrow Articles by Schmidt, J. J.
Right arrow Articles by Stafford, R. G.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, January 2003, p. 297-303, Vol. 69, No. 1
0099-2240/03/$08.00+0     DOI: 10.1128/AEM.69.1.297-303.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Fluorigenic Substrates for the Protease Activities of Botulinum Neurotoxins, Serotypes A, B, and F

James J. Schmidt* and Robert G. Stafford

Toxinology and Aerobiology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011

Received 3 June 2002/ Accepted 8 October 2002

The seven botulinum neurotoxins (BoNTs) are zinc metalloproteases that cleave neuronal proteins involved in neurotransmitter release and are among the most toxic natural products known. High-throughput BoNT assays are needed for use in antibotulinum drug discovery and to characterize BoNT protease activities. Compared to other proteases, BoNTs exhibit unusually stringent substrate requirements with respect to amino acid sequences and polypeptide lengths. Nonetheless, we have devised a strategy for development of fluorigenic BoNT protease assays, based on earlier structure-function studies, that has proven successful for three of the seven serotypes: A, B, and F. In synthetic peptide substrates, the P1 and P3' residues were substituted with 2,4-dinitrophenyl-lysine and S-(N-[4-methyl-7-dimethylamino-coumarin-3-yl]-carboxamidomethyl)-cysteine, respectively. By monitoring the BoNT-catalyzed increase in fluorescence over time, initial hydrolysis rates could be obtained in 1 to 2 min when BoNT concentrations were 60 ng/ml (about 1 nM) or higher. Each BoNT cleaved its fluorigenic substrate at the same location as in the neuronal target protein, and kinetic constants indicated that the substrates were selective and efficient. The fluorigenic assay for BoNT B was used to characterize a new competitive inhibitor of BoNT B protease activity with a Ki value of 4 µM. In addition to real-time activity measurements, toxin concentration determinations, and kinetic studies, the BoNT substrates described herein may be directly incorporated into automated high-throughput assay systems to screen large numbers of compounds for potential antibotulinum drugs.


* Corresponding author. Mailing address: Toxinology and Aerobiology Division, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter St., Fort Detrick, MD 21702-5011. Phone: (301) 619-4240. Fax: (301) 619-2348. E-mail: james.schmidt{at}det.amedd.army.mil.


Applied and Environmental Microbiology, January 2003, p. 297-303, Vol. 69, No. 1
0099-2240/03/$08.00+0     DOI: 10.1128/AEM.69.1.297-303.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Poras, H., Ouimet, T., Orng, S.-V., Fournie-Zaluski, M.-C., Popoff, M. R., Roques, B. P. (2009). Detection and Quantification of Botulinum Neurotoxin Type A by a Novel Rapid In Vitro Fluorimetric Assay. Appl. Environ. Microbiol. 75: 4382-4390 [Abstract] [Full Text]  
  • Al-Saleem, F. H., Ancharski, D. M., Ravichandran, E., Joshi, S. G., Singh, A. K., Gong, Y., Simpson, L. L. (2008). The Role of Systemic Handling in the Pathophysiologic Actions of Botulinum Toxin. J. Pharmacol. Exp. Ther. 326: 856-863 [Abstract] [Full Text]  
  • Rasooly, R., Do, P. M. (2008). Development of an In Vitro Activity Assay as an Alternative to the Mouse Bioassay for Clostridium botulinum Neurotoxin Type A. Appl. Environ. Microbiol. 74: 4309-4313 [Abstract] [Full Text]  
  • Hines, H. B., Kim, A. D., Stafford, R. G., Badie, S. S., Brueggeman, E. E., Newman, D. J., Schmidt, J. J. (2008). Use of a Recombinant Fluorescent Substrate with Cleavage Sites for All Botulinum Neurotoxins in High-Throughput Screening of Natural Product Extracts for Inhibitors of Serotypes A, B, and E. Appl. Environ. Microbiol. 74: 653-659 [Abstract] [Full Text]  
  • Burnett, J. C., Ruthel, G., Stegmann, C. M., Panchal, R. G., Nguyen, T. L., Hermone, A. R., Stafford, R. G., Lane, D. J., Kenny, T. A., McGrath, C. F., Wipf, P., Stahl, A. M., Schmidt, J. J., Gussio, R., Brunger, A. T., Bavari, S. (2007). Inhibition of Metalloprotease Botulinum Serotype A from a Pseudo-peptide Binding Mode to a Small Molecule That Is Active in Primary Neurons. J. Biol. Chem. 282: 5004-5014 [Abstract] [Full Text]  
  • Ravichandran, E., Gong, Y., Saleem, F. H. A., Ancharski, D. M., Joshi, S. G., Simpson, L. L. (2006). An Initial Assessment of the Systemic Pharmacokinetics of Botulinum Toxin. J. Pharmacol. Exp. Ther. 318: 1343-1351 [Abstract] [Full Text]  
  • Dong, M., Tepp, W. H., Johnson, E. A., Chapman, E. R. (2004). Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells. Proc. Natl. Acad. Sci. USA 101: 14701-14706 [Abstract] [Full Text]  
  • Barth, H., Aktories, K., Popoff, M. R., Stiles, B. G. (2004). Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins. Microbiol. Mol. Biol. Rev. 68: 373-402 [Abstract] [Full Text]